SynthesisFrontiers in public health2026
From economic burden to patient-centered solutions: the evolving landscape of financial toxicity in oncology.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mapping the health management journey of allogeneic hematopoietic stem cell transplantation: a qualitative study.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Financial burden has emerged as a significant challenge in oncology, adversely affecting patients' quality of life, treatment adherence, and long-term outcomes. While research on cancer-related financial toxicity (FT) has grown rapidly, a comprehensive bibliometric analysis of its knowledge structure, thematic evolution, and emerging trends remains scarce. Methods: Publications on FT among cancer patients, published from 2003 to January 19, 2026, were retrieved from the Web of Science Core Collection and Scopus databases. Bibliometric and science mapping analyses were conducted using CiteSpace, VOSviewer, and R software to assess publication trends, collaboration networks, research hotspots, and thematic evolution. Results: Research on FT in cancer patients has experienced substantial growth over the past two decades, with increasing interdisciplinary integration. The focus has shifted from descriptive economic burden assessments to patient-centered and system-oriented approaches, conceptualizing FT as a modifiable risk embedded within social and clinical contexts. Social support and multidisciplinary management have emerged as major interconnected research hotspots, emphasizing that effective mitigation of FT requires addressing both upstream social determinants of health and downstream integration of coordinated clinical interventions. Emerging keywords suggest that measurement and conceptualization, behavioral consequences, socioeconomic impact, and intervention & health system response are likely to influence future research directions. Conclusion: This bibliometric analysis reveals that FT research has evolved into a comprehensive conceptual framework, positioning FT as a modifiable, system-level risk in cancer care. By synthesizing evidence on social support and multidisciplinary management, this study proposes a model linking social determinants, clinical assessment, and coordinated interventions. These findings offer valuable insights to guide future research and the development of targeted strategies aimed at alleviating financial burden and improving survivorship care, supporting the integration of FT management into patient-centered oncology practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.